Posts Tagged ‘healthtech’
Healthtech spotlight: Jack Fertility
Jack Fertility has recently launched its £500K fundraising campaign to bring the world’s first home-to-lab sperm test kit to market. We had a chat with Co-founders, Lily Elsner and Nick Shipley, to hear their story… Jack Fertility at a glance: Start date: 2022 Market sector: Healthtech Location: Oxford Number of employees: 3 Amount of funding raised: £125k + government…
Read MoreCell technology spinout Impulsonics closes £450k funding
Impulsonics has closed its first funding round to advance the development of its unique biotech automation platform and begin customer trials. Impulsonics is an award-winning cell technology spinout from the University of Bristol’s Ultrasonics and Non-Destructive Testing Research Group, building on over a decade of deep research and leveraging world-leading expertise in acoustics. The company…
Read MoreMedtech startup Neuronostics raises over £2 million
Multi-award-winning medtech startup, Neuronostics, has raised more than £2m in funding to develop its pioneering epilepsy diagnosis technology. The company received £2.1m in an oversubscribed seed funding round led by the Ascension Life Fund. Chris Wheatcroft, Investment Director at the Ascension Life Fund said: “We are delighted to have invested in Neuronostics, whose software as…
Read MoreBiotech startup Impulsonics awarded £300,000 Innovate UK grant
Bristol-based startup, Impulsonics has been awarded the prestigious ICURe spinout support grant of £300,000 to enable the development of its unique technology platform for biotech automation. The grant will enable the company to develop its flexible acoustic platform for key applications in the process of growing cells in order to streamline cell culture automation. This…
Read MoreSiloton co-founders awarded Institute of Physics’ Clifford Paterson Medal
Dr Alasdair Price and Dr Euan Allen, Co-founders of healthtech startup Siloton, have been awarded the Institute of Physics’ Clifford Paterson Medal for ‘exceptional early-career contributions to the application of physics in an industrial or commercial context’. Siloton joined SETsquared Bristol’s incubation programme in January 2023 to further develop its innovative diagnostic imaging technology to…
Read MoreMoropo releases innovative app testing tool
Bristol tech company Moropo has launched a new mobile app testing tool for software agencies and startups. The web-based automation platform comprises a low-code test creator, a test scheduling system and a results inspector, and works for both iOS and Android. Moropo joined SETsquared Bristol in March 2022 and has since secured over £340,000 in…
Read MoreBehind Login: Competitor intelligence for fintech companies
Behind Login has built a successful consultancy business to invest in its competitor intelligence platform for fintech companies. We had a chat with Founder and Director, Oliver Lane, to hear his story… Behind Login key facts Start date: January 2022 Market sector: Market intelligence/competitor research within fintech Location: Bristol Number of employees: 7 Company growth status: Startup In your own words…
Read MoreActuation Lab secures £3m contract to support decarbonisation with hydrogen
Low carbon hydrogen will be critical to the decarbonisation of the global energy supply. However, hydrogen has an extremely high leak propensity and a global warming potential 12 times greater than carbon dioxide if it escapes into the atmosphere. The risks of ignition associated with hydrogen are significant, particularly in enclosed spaces. To support the…
Read MoreSiloton: Photonics technology to prevent sight loss
Following our member company Siloton’s £470k raise, which will further fund its diagnostic imaging technology to prevent sight loss, we had a chat with Co-founder and CEO, Alasdair Price, to hear his story… Siloton key facts Start date: 1 April 2020 Market sector: Healthtech Location: Bristol Company growth status: Seed Stage In your own words, what does Siloton do? Siloton…
Read MoreRosa Biotech secures £415,000 to accelerate early disease screening
Bio-sensing pioneer Rosa Biotech has secured £415,000 from angel investors and announced plans to accelerate development of its bio-sensing technology, designed to enable cost effective, early-stage screening of a range of life-threatening diseases. The University of Bristol healthtech spinout joined SETsquared Bristol in February 2023. It is initially targeting the early identification of non-alcoholic fatty…
Read More